Medical News

RSS

KCI to conduct discussion on limb surgeries and amputations

Kinetic Concepts, Inc. (KCI) will sponsor a CME-accredited panel discussion, “The Role of NPWT in the Team Approach to Limb Salvage: Case Studies,” at the 3rd Annual Georgetown Diabetic Limb Salvage conference September 24-26.

19 Sep 2009

Health experts to discuss innovative breakthroughs to solve health issues in poor communities

New ideas, systems and technologies are emerging to solve numerous health challenges facing the world’s poorest communities. Some of the foremost experts on global health will discuss these and the prospects for health breakthroughs in the developing world at a media briefing at the Conrad N. Hilton Humanitarian Symposium at 2:30 pm on Monday, September 21.

19 Sep 2009

Health Discovery Corporation appoints new COO

Health Discovery Corporation, a personalized medicine company specializing in molecular diagnostics including gene-based testing, as well as computer assisted diagnostics in digital pathology and radiology, announced that former Deputy FDA Commissioner John A. Norris has been appointed as Chief Operating Officer (COO) of the Company.

19 Sep 2009

Nasdaq issues noncompliance letter regarding bid price to La Jolla Pharmaceutical

La Jolla Pharmaceutical Company (Nasdaq: LJPC) announced today that it has received a notice from the Nasdaq Stock Market indicating that the Company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Rule”) because, for the last 30 consecutive days, the bid price for the Company’s common stock has closed below the minimum level of $1.00 per share.

19 Sep 2009

NASDAQ issues noncompliance letter to Hytham, grants grace period till March 15, 2010

Hythiam, Inc. (NASDAQ:HYTM) announced today that on September 15, 2009, the Company received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company’s common stock had closed below the minimum $1.00 per share threshold as set forth in NASDAQ Listing Rule 5450(a)(1) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement.

19 Sep 2009

Ethridge Plastic Surgery focuses on personalized reconstructive procedures

A Fort Worth plastic surgeon, Richard T. Ethridge, M.D., P.A., strives to promote health and well-being through a comprehensive and personalized approach to rejuvenative and reconstructive surgery. Dr. Ethridge specializes in plastic and reconstructive surgery, with a focus on cosmetic and reconstructive procedures of the breast, body, and face.

19 Sep 2009

Medtronic to showcase cardiovascular product portfolio at TCT 2009

Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its innovative cardiovascular product portfolio, technology pipeline and clinical research at the world’s premier annual meeting for interventional cardiologists.

19 Sep 2009

Quidel's updates information on its Influenza A+B test package insert

Quidel Corporation, a global leader in point-of-care (POC) rapid diagnostic tests, issues clarification regarding the Special 510(k) clearance for an update to the Company's QuickVue Influenza A+B test package insert.

19 Sep 2009

Nasdaq Stock Market issues deficiency letter regarding bid price to Ore Pharmaceuticals

Ore Pharmaceuticals Inc. (“Ore”) announced today the receipt of a written notice from the Nasdaq Stock Market ("Nasdaq") stating that for the previous 30 consecutive business days, the bid price of Ore’s listed securities had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market pursuant to Marketplace Rule 5550(a)(2).

19 Sep 2009

Campaign for Disability Employment launched

Last evening at the U.S. Business Leadership Network's (USBLN) Annual Conference and National Career Fair, several leading disability organizations launched the Campaign for Disability Employment, a new collaborative effort to promote positive employment outcomes for people with disabilities.

19 Sep 2009

Pharmacist Paul Dwork endorses the Protectus Safety Syringe

E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a letter from Paul Dwork, Pharmacist, and President of Merlin Medical Supply Pharmacy, endorsing the many benefits of the Protectus Safety Syringe.

19 Sep 2009

Mark Farrah develops new database tool for comparative analysis of Medicare Advantage and PDP benefit packages

In a recent customer update, Mark Farrah Associates confirmed that Medicare Advantage membership continues to climb, prior to the 2010 open enrollment season.

19 Sep 2009

State of Virginia implements touch screen check in systems for customer service

In an effort to reduce overhead in court systems and probation offices, the State of Virginia has implemented kiosk style check in systems in many of the offices statewide.

19 Sep 2009

Tips for preventing mold exposure

In recognition of Mold Awareness Month this month, cleanup and restoration professionals are explaining how mold can affect anyone who is exposed to it.

19 Sep 2009

NASDAQ issues noncompliance letter to GTC Biotherapeutics

GTC Biotherapeutics, Inc.’s ("GTC", NASDAQ: GTCB) received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market (the “Staff Determination”) on September 17, 2009, indicating that unless GTC requests a hearing before the NASDAQ Listing Qualifications Panel (the “Panel”), the Company’s securities would be subject to delisting from The NASDAQ Capital Market due to non-compliance with the $35 million market value of listed securities requirement as set forth in Listing Rule 5550(b)(2).

19 Sep 2009

MedWaves reports on its ongoing studies using the AveCure microwave coagulation-ablation system

MedWaves, Inc. announces ongoing investigational studies to determine the effectiveness of its microwave ablation system for treating soft tissue lesions, such as tumors, in liver and lung. The studies using MedWaves' AveCure(TM) microwave coagulation-ablation system, which includes a generator and probe/antenna (FDA 510(k) cleared and CE Mark certified), are showing promising results.

19 Sep 2009

New head appointed at NeuroFocus' neurological testing laboratory facility

...

19 Sep 2009

Survey reveals that patients face problems with mail order pharmacies

Many patients go without their prescribed medicine due to the slow or ineffective service of mail order pharmacies, according to a survey of just over 400 patients conducted by the National Community Pharmacists Association (NCPA). The findings both raise troubling questions about the impact mail-order programs have on patients and contradict two purported benefits of mail order: increased convenience and lower costs.

19 Sep 2009

Del Monte Foods sponsors the San Francisco Heart Walk

Del Monte Foods today continues its commitment to healthy diet and lifestyles and the prevention of heart disease and stroke as the returning Presenting Sponsor of the American Heart Association 2009 Start! San Francisco Heart Walk.

19 Sep 2009

Positron to promote its Attrius cardiac optimized PET scanner at the MedAxiom Fall Conference

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, will attend MedAxiom’s Fall Conference in Dana Point, California September 23rd, 2009 to promote their cardiac optimized PET scanner, the Attrius™ (www.medaxiom.com).

19 Sep 2009